Stay updated on EGFR Mutant Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.
Latest updates to the EGFR Mutant Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.3 is now displayed in the footer; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.3.2 updated from v3.3.1; no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page now displays revision v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check55 days agoChange DetectedThe government funding status notice was removed from the page; no other trial details, eligibility criteria, or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check69 days agoChange DetectedNo substantive differences detected between the two screenshots. The study design, eligibility criteria, outcomes, and locations appear unchanged.SummaryDifference0.5%
- Check98 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%
Stay in the know with updates to EGFR Mutant Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.